WRF Capital
Corporate VCSeattle · Pre-Seed–Series B · 19 people tracked
Investment thesis
WRF Capital invests roughly $5 million annually in Washington-based startups, focusing on spinouts from state nonprofit research institutions such as UW, WSU, Fred Hutch and ISB. It backs pre-seed through Series A companies across life sciences and enabling technologies, with initial checks of $100,000 to $2 million and reserves for follow-ons. Often the first money in, the firm partners with angels and VCs across rounds and can lead investments, syndicating with value-adding firms. It emphasizes rigorous due diligence and selective investing to help commercialize new technologies developed in Washington.
Source: firm website, verified Aug 3, 2026.
Team · 19 people
from the firm's websiteWhat they invest in
from 5 of 5 portfolio companiesBiotech ×3EdTech ×2Healthtech ×1
HQs:United States×4
Investments · 5 tracked
founders shown can be your intro pathBiotechSeattle, US
Matthew Bick(Executive Officer, Director, Promoter)Javier Castellanos(Executive Officer, Director, Promoter)Hector De Jesus Rincon Arano(Executive Officer, Promoter)Heather Redman(Director)Randall Schatzman(Director)William Canestaro(Executive Officer)
Fred Hutch is a cancer treatment and research organization providing patient care, clinical trials, and research into the prevention, early detection, and treatment of cancer, HIV, and other diseases.
BiotechHealthtech
Washington State University is a public research university offering hundreds of degree programs across six campuses, with research and extension operations throughout Washington state.
EdTech
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does WRF Capital invest at?
- WRF Capital invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is WRF Capital's typical check size?
- WRF Capital typically writes checks of $100K – $2M.
- What sectors does WRF Capital focus on?
- WRF Capital focuses on Biotech, Consumer, Data & Infrastructure, Deep Tech, Digital Health, Enterprise Software, Hardware, Healthtech, Medical Devices, New Materials, SaaS.
- Where is WRF Capital located?
- WRF Capital is headquartered in Seattle, US.
- Does WRF Capital lead rounds?
- Yes, WRF Capital leads investment rounds.
Co-investors · 1
Early-stage venture capital firm focused on digital health innovations including digital diagnostics, digital therapeutics, and tech-enabled services. Based in Boston and Philadelphia with deep clinical expertise and experience building and scaling healthcare ventures.
Firms observed investing alongside WRF Capital, from public investor directories. Shared companies are the overlap with WRF Capital's recorded portfolio.
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Karista is a French venture capital firm that invests in tech and early-stage companies, frequently leading funding rounds and supporting founders through strategic guidance and board involvement.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
OMERS Ventures is the venture capital arm of the OMERS pension plan, investing in early-stage technology founders building solutions across North America and Europe.
SBI Investment Korea is a Korean asset management firm within the SBI Group that operates venture capital and private equity funds, positioning itself as a 'New Industry Creator'.


















